Next Article in Journal
Survival Analysis in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Chemoradiotherapy Followed by Surgery According to the International Consensus on the 2017 Definition of Borderline Resectable Cancer
Next Article in Special Issue
The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
Previous Article in Journal
Kinases and Cancer
Previous Article in Special Issue
Tumor Resistance against ALK Targeted Therapy-Where It Comes From and Where It Goes
Article Menu
Issue 3 (March) cover image

Export Article

Open AccessReview
Cancers 2018, 10(3), 64; https://doi.org/10.3390/cancers10030064

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability

1
Central European Institute of Technology (CEITEC), Masaryk University, Kamenice 5, 62500 Brno, Czech Republic
2
Department of Internal Medicine—Hematology and Oncology, University Hospital Brno, 62500 Brno, Czech Republic
*
Author to whom correspondence should be addressed.
Received: 26 January 2018 / Revised: 20 February 2018 / Accepted: 27 February 2018 / Published: 5 March 2018
Full-Text   |   PDF [1765 KB, uploaded 5 March 2018]   |  

Abstract

Genomic stability is crucial for cell life and transmitting genetic material is one of the primary tasks of the cell. The cell needs to be able to recognize any possible error and quickly repair it, and thus, cells have developed several mechanisms to detect DNA damage and promote repair during evolution. The DNA damage response (DDR) and DNA repair pathways ensure the control of possible errors that could impair the duplication of genetic information and introduce variants in the DNA. Endogenous and exogenous factors compromise genomic stability and cause dysregulation in the DDR and DNA repair pathways. Cancer cells often impair these mechanisms to overcome cellular barriers (cellular senescence and/or apoptosis), leading to malignancy. NPM (nucleophosmin)-ALK (anaplastic lymphoma kinase) is an oncogenic tyrosine kinase that is involved in the development of anaplastic large cell lymphoma (ALCL). NPM-ALK is known to be involved in the activation of proliferative and anti-apoptotic signaling pathways. New evidence reveals that NPM-ALK translocation also impairs the ability of cells to maintain the genomic stability through both DDR and DNA repair pathways. This review aims to highlight the role of the oncogenic tyrosine kinase NPM-ALK in the cell, and pointing to new possible therapeutic strategies. View Full-Text
Keywords: NPM-ALK (nucleophosmin-anaplastic lymphoma kinase); ALK; anaplastic large cell lymphoma (ALCL); DNA damage response; genomic instability; DNA repair; p53; MutS protein homolog 2 (MSH2) NPM-ALK (nucleophosmin-anaplastic lymphoma kinase); ALK; anaplastic large cell lymphoma (ALCL); DNA damage response; genomic instability; DNA repair; p53; MutS protein homolog 2 (MSH2)
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Lobello, C.; Bikos, V.; Janikova, A.; Pospisilova, S. The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability. Cancers 2018, 10, 64.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top